Clarifications regarding bumetanide for neonatal seizures
Sign Up to like & getrecommendations! Published in 2022 at "Epilepsia"
DOI: 10.1111/epi.17278
Abstract: A recent Phase II randomized, controlled trial of bumetanide as an adjunctive treatment for neonatal seizures showed a robust efficacy signal and no evidence of toxicity. Concerns regarding bumetanide as an adjunctive anticonvulsant are addressed… read more here.
Keywords: bumetanide neonatal; clarifications regarding; neonatal seizures; regarding bumetanide ... See more keywords